Help Beta Test Our Site and Be Eligible to Purchase Shares= of=20 Future IPOs In Which We Participate**

eMedsecurities has selected you as a possible participant = to help=20 test our online stock-trading engine for knowledge-based investing = in the=20 life sciences. For your cooperation, you will be eligible = to purchase=20 shares of future IPOs in which we participate, for as long as y= ou=20 maintain your account with us. This is limited to only 50 = qualified=20 testers! Request M= ore Information.**

eMedsecurities=85 The Cure for the Common Portfolio!

eMedsecurities provides you with a wealth of information, = all=20 compiled in a single, easy-to-use resource. Learn about new r= esearch=20 and upcoming treatments for diabetes, glaucoma, cataract, obesity a= nd much more. Obtain critical investment information about the=20 companies that are developing these treatments. eMedsecuritie= s empowers=20 you to make more informed investment decisions. Request More Information.**

Participation i= n eMedsecurities's Beta Test allows you:

Eligibility to purchase s= hares of IPOs in which=20 eMedsecurities participates for as long as you maintain your=20 account**
Valuable research of the = entire product=20 pipeline of companies, including stages of clinical development, = by=20 industry or specific disease
Useful information about = industry trends, recent=20 developments and upcoming IPOs
Commitment to customer se= rvice featuring=20 our Live Customer Service Online
Dedication to fast trade = executions at the best=20 possible price.

The following guideline= s will=20 explain what we expect from an eMedsecurities Beta Tester:

Open a funded eMedsecurities=20 account
Visit our online trading site onc= e=20 a week
Execute trades through our Web=20 site in accordance with your normal practice
Submit feedback to eMedsecurities= 's development team through a questionnaire sent via=20 email
Provide us with additional=20 feedback regarding the site as needed.

The test is limited to = only 50 Beta=20 Testers so sign up now to be considered! Request More Information.**=20

Please note:<= /B> All applications for the Beta Test must be s= ubmitted by January 25, 2001 to be considered.=20

Please=20 be advised that your information will stay in our proprietary datab= ase and=20 will not be sold, traded, given or otherwise provided to outside ve= ndors. We respect your privacy.=20

=20

By=20 submitting your information, you implicitly state that this is some= thing=20 that interests you and that you
agree to receive periodic emails from=20 eMedsecurities.=20

Research indicated= that you=20 might benefit from our offer. To be removed instantly and per= manently from=20 our database, simply click here= . We respect=20 all removal requests.

** R= estrictions=20 Apply: Beta test not open t= o residents of HI, IL, MI, MN, NE, NH, TN, TX. Initial Public=20 Offerings are considered speculative investments and as such may no= t be=20 appropriate for every investor. If an investor chooses to participa= te in=20 IPOs, there are certain restrictions that apply. Flipping - The first time an invest= or sells their shares within the first 30 days the issue is trading in the=20 secondary market, that investor will not be allocated shares for th= e next=20 90 days following the sale. The second time that investor =93= flips,"=20 they will not be allocated IPO shares for 180 days. The third= time=20 that investor =93flips," they lose their IPO allocations perma= nently. Transferring shares - If the=20 investor transfers IPO shares out of their account within the first= 30=20 days the issue is trading in the secondary market, they will perman= ently=20 lose their IPO allocations. Beta investors will be chosen = from=20 all the applicants based on their income, net worth and investing=20 experience. Beta Test open only to those 21 years of age= or older. IPO shares will only be allocated from transactions in=20 which eMedsecurities participates in the underwriting. A0009-= 1-A2
eMedsecurities, Inc. Member NASD SIPC.